Thomas Steckler

Research interests

Publications

• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*

  Journal of Cerebral Blood Flow & Metabolism · 2020 · https://doi.org/10.1177/0271678x20943823

• Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0

  PLoS Biology · 2020 · https://doi.org/10.1371/journal.pbio.3000411

• The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

  PLoS Biology · 2020 · https://doi.org/10.1371/journal.pbio.3000410

• The ARRIVE guidelines 2.0: updated guidelines for reporting animal researchThe ARRIVE guidelines 2.0: updated guidelines for reporting animal research

  BMJ Open Science · 2020 · https://doi.org/10.1136/bmjos-2020-100115

• The ARRIVE guidelines 2.0: updated guidelines for reporting animal research

  The Journal of Physiology · 2020 · https://doi.org/10.1113/jp280389

• Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019

  bioRxiv (Cold Spring Harbor Laboratory) · 2019 · https://doi.org/10.1101/703355

• The ARRIVE guidelines 2019: updated guidelines for reporting animal research

  bioRxiv (Cold Spring Harbor Laboratory) · 2019 · https://doi.org/10.1101/703181

• Editorial: preclinical data reproducibility for R&D - the challenge for neuroscience

  SpringerPlus · 2015 · https://doi.org/10.1186/2193-1801-4-1

• Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

  European Neuropsychopharmacology · 2014 · https://doi.org/10.1016/j.euroneuro.2014.03.008

• Pharmacological treatment of PTSD – Established and new approaches

  Neuropharmacology · 2011 · 10.1016/j.neuropharm.2011.06.012

• NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis

  Neuropharmacology · 2011 · 10.1016/j.neuropharm.2011.03.015

• Summary of Product Characteristics

  Journal · 2010 · https://doi.org/10.1007/978-3-540-68706-1_698

• Behavioral Neurobiology of Anxiety and Its Treatment

  Current topics in behavioral neurosciences · 2010 · https://doi.org/10.1007/978-3-642-02912-7

• Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

  Neuropsychopharmacology · 2008 · https://doi.org/10.1038/npp.2008.173

• Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania

  Journal of Neuroscience · 2006 · https://doi.org/10.1523/jneurosci.5216-05.2006

• Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

  Trends in Pharmacological Sciences · 2003 · https://doi.org/10.1016/j.tips.2003.09.011

• Effects of transgenic overproduction of CRH on anxiety‐like behaviour

  European Journal of Neuroscience · 2002 · 10.1046/j.1460-9568.2002.02040.x

• Behavioural analysis of four mouse strains in an anxiety test battery

  Behavioural Brain Research · 2000 · https://doi.org/10.1016/s0166-4328(00)00240-0

• Genome-wide, large-scale production of mutant mice by ENU mutagenesis

  Nature Genetics · 2000 · https://doi.org/10.1038/78146

• Glucocorticoids and depression

  Best Practice & Research Clinical Endocrinology & Metabolism · 1999 · https://doi.org/10.1053/beem.1999.0046

• Corticotropin-releasing hormone receptor subtypes and emotion

  Biological Psychiatry · 1999 · https://doi.org/10.1016/s0006-3223(99)00170-5

• Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1

  Nature Genetics · 1998 · https://doi.org/10.1038/520

• The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour

  Behavioural Brain Research · 1995 · https://doi.org/10.1016/0166-4328(94)00157-b

Current projects

No projects listed.